Lv6
1870 积分 2023-03-01 加入
ORGAN-SPECIFIC DELIVERY OF AN MRNA-ENCODED BISPECIFIC T CELL ENGAGER TARGETING GLYPICAN-3 IN HEPATOCELLULAR CARCINOMA
1个月前
已完结
How good enough are the new therapies for lupus nephritis? A narrative review and a position paper
1个月前
已关闭
CAR T-cell therapy in SLE: A systematic review
2个月前
已完结
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
2个月前
已完结
Clinical Manufacturing of Tumor-Infiltrating Lymphocytes (TIL): Combining TIL Outgrowth and Rapid Expansion On A Closed and Automated Platform
4个月前
已完结
Fast tumor-infiltrating lymphocytes (TILs): rapid manufacture of an adoptive cellular therapeutic from pleural infiltrating T cells for intrapleural administration
4个月前
已关闭
As Fast As We Can: Rational Design of Rapid Chimeric Antigen Receptor T Cell Manufacturing
4个月前
已完结
Rapid manufacturing of non-activated potent CAR T cells
4个月前
已完结
CAR-T Rapid Manufacturing: Implications on Product and Analytical Testing
4个月前
已完结
Optimizing CAR T cell therapy for solid tumours: a clinical perspective
4个月前
已完结
皖公网安备34019202002308
